GREECE - Redefining the Future of Life Sciences: Business & Investment Networking Event

​Headline: Greece - Redefining the Future of Life Sciences

​On the occasion of the Greek Biotech and Life Sciences Business Mission to San Francisco, the Consul General of Greece, Mr. Grigorios Tassiopoulos, requests the pleasure of your company at a focused Business & Investment Networking Event.

​This curated gathering will bring together selected Bay Area investors, VCs, biotech executives, research institutions and ecosystem stakeholders with nine (9) elite Greek start-ups, scale-ups and innovation platforms operating across:

• ​precision diagnostics and liquid biopsy

• ​oncology and regenerative medicine

• ​AI-enabled drug repurposing

• ​therapeutics for neurodegenerative diseases

• ​CRO and regulatory services

• ​pharmaceutical manufacturing

• ​biotech infrastructure and innovation support services

​Partnership Opportunities: The participating companies are actively seeking investment opportunities, strategic pharma and biotech partnerships, clinical and hospital collaborations, co-development initiatives, distribution channels, CRO alliances, and partnerships supporting EU market entry and broader European expansion.

​Coordinated by Enterprise Greece in collaboration with HBio - Hellenic BioCluster.

​Agenda

​12:00–12:30 | Welcome coffee and registration

​12:30–12:35 | Welcome remarks by H.E., Mr. Grigorios Tassiopoulos, Consul General of Greece in San Francisco

​12:35–12:45 | Dr. Marinos Giannopoulos, CEO, Enterprise Greece

​12:45–12:55 | Dr. Ioanna Koukli, President, Hellenic Bio-Cluster (HBio)

​12:55–13:05 | Ms. Katerina Sokou, Executive Director, American-Hellenic Chamber of Commerce USA

​13:05–13:45 | Greek company spotlight session | Short 3-minute presentations by the participating Greek companies

​13:45-15:00 | Networking and Light Lunch Reception